Cationic Lipid Pairs Enhance Liver-to-Lung Tropism of Lipid Nanoparticles for In Vivo mRNA Delivery
ACS Applied Materials & Interfaces · 2024
DOI: 10.1021/acsami.4c02415 ↗At a glance
Journal article in ACS Applied Materials & Interfaces, 2024. Written by Gege Zeng and 7 co-authors. Institution: School of Materials Science and Engineering, Key Laboratory for Polymeric Composite and Functional Materials of Ministry of Education, Guangdong Func…. Major MEDLINE topics: Nanoparticles, Lung, RNA, Messenger, Lipids. Cited 32 times so far (Crossref); 48 references. Funded by: National Natural Science Foundation of China.
Abstract (original language)
Much of current clinical interest has focused on mRNA therapeutics for the treatment of lung-associated diseases, such as infections, genetic disorders, and cancers. However, the safe and efficient delivery of mRNA therapeutics to the lungs, especially to different pulmonary cell types, is still a formidable challenge. In this paper, we proposed a cationic lipid pair (CLP) strategy, which utilized the liver-targeted ionizable lipid and its derived quaternary ammonium lipid as the CLP to improve liver-to-lung tropism of four-component lipid nanoparticles (LNPs) for in vivo mRNA delivery. Interestingly, the structure-activity investigation identified that using liver-targeted ionizable lipids with higher mRNA delivery performance and their derived lipid counterparts is the optimal CLP design for improving lung-targeted mRNA delivery. The CLP strategy was also verified to be universal and suitable for clinically available ionizable lipids such as SM-102 and ALC-0315 to develop lung-targeted LNP delivery systems. Moreover, we demonstrated that CLP-based LNPs were safe and exhibited potent mRNA transfection in pulmonary endothelial and epithelial cells. As a result, we provided a powerful CLP strategy for shifting the mRNA delivery preference of LNPs from the liver to the lungs, exhibiting great potential for broadening the application scenario of mRNA-based therapy.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- School of Materials Science and Engineering, Key Laboratory for Polymeric Composite and Functional Materials of Ministry of Education, Guangdong Functional Biomaterials Engineering Technology Research Center, Sun Yat-se…
- Laboratory of Biomaterials and Translational Medicine, Center for Nanomedicine, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou 510630, China.
- State Key Laboratory of Oncology in South China, Guangzhou 510060, China.
- College of Chemistry and Molecular Science, Henan University, Zhengzhou 475001, China.
ORCID profiles: Lixin Liu, Zhijia Liu, Yongming Chen
Funding
- National Natural Science Foundation of China
Cite
APA
Zeng, G., He, Z., Yang, H., Gao, Z., Ge, X., Liu, L., Liu, Z., & Chen, Y. (2024). Cationic Lipid Pairs Enhance Liver-to-Lung Tropism of Lipid Nanoparticles for In Vivo mRNA Delivery. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.4c02415
Vancouver
Zeng G, He Z, Yang H, Gao Z, Ge X, Liu L, et al. Cationic Lipid Pairs Enhance Liver-to-Lung Tropism of Lipid Nanoparticles for In Vivo mRNA Delivery. ACS Applied Materials & Interfaces. 2024. doi:10.1021/acsami.4c02415
BibTeX
@article{Zeng2024,
author = {Zeng, Gege and He, Zepeng and Yang, Haihong and Gao, Zhan and Ge, Xueer and Liu, Lixin and Liu, Zhijia and Chen, Yongming},
title = {Cationic Lipid Pairs Enhance Liver-to-Lung Tropism of Lipid Nanoparticles for In Vivo mRNA Delivery},
journal = {ACS Applied Materials & Interfaces},
year = {2024},
doi = {10.1021/acsami.4c02415}
}
EUVIMED